Key result
Extending the flushing interval of totally implantable vascular access devices up to 8 weeks is proposed as a necessary strategy change compared to the traditional 4-week interval.
Why the study?
Can the flushing interval for totally implantable vascular access devices (TIVADs) in cancer patients be safely extended from 4 weeks to 8 weeks?
Can the flushing interval for totally implantable vascular access devices (TIVADs) in cancer patients be safely extended from 4 weeks to 8 weeks?
This editorial advocates for a revision of guidelines to extend the flushing interval of TIVADs in cancer patients to at least 8 weeks, potentially improving patient convenience and reducing healthcare burden.
Several recent literature reports regarding the flushing technique of TIVADs highlight how the definition of the optimal flushing interval is still a source of controversy. Several recent studies indicate more and more frequently how 4 weeks can be considered a too short interval for the flushing of a totally implantable access device (TIVAD); on the other hand most of the main guidelines and instructions for use provided by the device's manufacturers still suggest an interval between 4 weeks and 1 month as the ideal one. The recent meta-analysis by Wu et al. on this topic, promotes an important strategy change, indicating the possibility of extending the flushing intervals at least up to 8 weeks. This editorial extensively discusses the flushing methods of TIVADs highlighting the need for important and substantial changes, both in extending the range of flushes and in the solutions and methods to be used. It represents an invitation to the scientific community and device manufacturers for a complete revision of the indications on flushing techniques.
No takes yet. Share an insight, caveat, or question.
Sergio Bertoglio (2020) conducted an editorial in Cancer patients with totally implantable vascular access devices (TIVADs). Extending flushing intervals up to 8 weeks vs. 4 weeks to 1 month interval was evaluated. Extending the flushing interval of totally implantable vascular access devices up to 8 weeks is proposed as a necessary strategy change compared to the traditional 4-week interval.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: